Tarsus Pharmaceuticals, Inc. (TARS) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 1250010,
    "name": "Tarsus Pharmaceuticals, Inc.",
    "stock_name": "Tarsus Pharmaceuticals, Inc.",
    "full_name": "Tarsus Pharmaceuticals, Inc.",
    "name_url": "stocks-analysis/tarsus-pharmaceuticals-inc",
    "exchange": 210,
    "exchangecode": "NAS",
    "country_id": 2,
    "currency": "USD",
    "cmp": "81.83",
    "chg": 2.39,
    "chgp": "3.01%",
    "dir": 1,
    "prev_price": "79.44",
    "mcapval": "2,401.56",
    "mcap": "Small Cap",
    "scripcode": "",
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 2305,
    "indexname": "S&P 500",
    "isin": "US87650L1035",
    "curr_date": "Dec 04",
    "curr_time": "",
    "bse_nse_vol": "607.28 k",
    "exc_status": "Active",
    "traded_date": "Dec 04, 2025",
    "traded_date_str": "2025 12 04",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/tarsus-pharmaceuticals-inc-1250010-210&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Tarsus Pharmaceuticals Hits Day High with 7.33% Surge in Stock Price",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/tarsus-pharmaceuticals-hits-day-high-with-733-surge-in-stock-price-3626749",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/TarsusPharmaceu_priceRelatedfactors_3626749.png",
        "date": "2025-10-16 19:06:27",
        "description": "Tarsus Pharmaceuticals, Inc. has shown strong stock performance, with significant gains over various time frames, including a 101.05% return over the past year. The company reported net sales of USD 102.66 million and increased stakeholder holdings, indicating rising confidence in its future prospects within the pharmaceuticals sector."
      },
      {
        "title": "Tarsus Pharmaceuticals Hits New 52-Week High of $75.01",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/tarsus-pharmaceuticals-hits-new-52-week-high-of-7501-3626674",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/TarsusPharmaceu_priceRelatedfactors_3626674.png",
        "date": "2025-10-16 18:29:12",
        "description": "Tarsus Pharmaceuticals, Inc. achieved a new 52-week high of USD 75.01 on October 15, 2025, reflecting a 131.18% increase over the past year. The company, with a market cap of USD 2,402 million, has shown positive sales growth and rising promoter confidence, enhancing its industry standing."
      },
      {
        "title": "Tarsus Pharmaceuticals Hits New 52-Week High of $71.15",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/tarsus-pharmaceuticals-hits-new-52-week-high-of-7115-3620159",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/TarsusPharmaceu_priceRelatedfactors_3620159.png",
        "date": "2025-10-14 18:57:26",
        "description": "Tarsus Pharmaceuticals, Inc. has achieved a new 52-week high, reflecting its strong performance in the pharmaceuticals and biotechnology sector. With a market capitalization of USD 2,402 million, the company has shown significant growth, positive quarterly results, and increasing promoter confidence, highlighting its resilience and commitment to future prospects."
      },
      {
        "title": "Tarsus Pharmaceuticals Hits New 52-Week High of $70.58",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/tarsus-pharmaceuticals-hits-new-52-week-high-of-7058-3608084",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/TarsusPharmaceu_priceRelatedfactors_3608084.png",
        "date": "2025-10-09 20:27:29",
        "description": "Tarsus Pharmaceuticals, Inc. achieved a new 52-week high on October 8, 2025, reflecting its strong performance in the pharmaceuticals and biotechnology sector. With a market cap of USD 2,402 million, the company has shown resilience despite losses, and promoter confidence is increasing as their stake rises."
      },
      {
        "title": "Tarsus Pharmaceuticals Hits New 52-Week High of $69.49",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/tarsus-pharmaceuticals-hits-new-52-week-high-of-6949-3604395",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/TarsusPharmaceu_priceRelatedfactors_3604395.png",
        "date": "2025-10-08 16:58:45",
        "description": "Tarsus Pharmaceuticals, Inc. achieved a new 52-week high of USD 69.49 on October 7, 2025, reflecting strong performance in the pharmaceuticals sector. With a market cap of USD 2,402 million and significant net sales, the company has seen increased promoter confidence and impressive one-year growth metrics."
      },
      {
        "title": "Tarsus Pharmaceuticals Hits New 52-Week High of $68.00",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/tarsus-pharmaceuticals-hits-new-52-week-high-of-6800-3601699",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/TarsusPharmaceu_priceRelatedfactors_3601699.png",
        "date": "2025-10-07 22:02:11",
        "description": "Tarsus Pharmaceuticals, Inc. achieved a new 52-week high of USD 68.00 on October 6, 2025, reflecting a 108.87% increase over the past year. The company, with a market cap of USD 2,402 million, has shown improving financial results and rising promoter confidence, indicating potential growth in the pharmaceuticals sector."
      },
      {
        "title": "Tarsus Pharmaceuticals Experiences Evaluation Revision Amid Strong Market Performance Indicators",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/tarsus-pharmaceuticals-technical-trend-shifts-from-mildly-bullish-to-bullish-amid-strong-performance-3601348",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/TarsusPharmaceu_technicaldot_3601348.png",
        "date": "2025-10-07 20:57:02",
        "description": "Tarsus Pharmaceuticals, Inc. has recently revised its evaluation amid strong market dynamics, with its stock price rising significantly. Over the past year, the company has achieved a remarkable return, outperforming the S&P 500. Technical indicators show a predominantly bullish sentiment, reflecting Tarsus's growth potential in the pharmaceuticals sector."
      },
      {
        "title": "Is Tarsus Pharmaceuticals, Inc. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-tarsus-pharmaceuticals-inc-technically-bullish-or-bearish-3599332",
        "imagepath": "",
        "date": "2025-10-07 12:24:17",
        "description": "As of 3 October 2025, the technical trend for Tarsus Pharmaceuticals, Inc. has changed from mildly bullish to bullish. The current stance is bullish with strong indicators supporting this view. The MACD is bullish on both the weekly and monthly time frames, and Bollinger Bands also indicate a bullish trend. Moving averages on the daily chart confirm this bullish sentiment. Although the KST shows a mildly bearish signal on the monthly, the overall Dow Theory is bullish for both weekly and monthly periods. \n\nIn terms of performance, Tarsus has significantly outperformed the S&P 500 across multiple periods, with a 1-year return of 99.81% compared to the S&P 500's 17.82%, and a 3-year return of 293.46% versus 82.57%...."
      },
      {
        "title": "Tarsus Pharmaceuticals Hits Day High with 10.89% Surge in Stock Price",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/tarsus-pharmaceuticals-hits-day-high-with-1089-surge-in-stock-price-3595726",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/TarsusPharmaceu_priceRelatedfactors_3595726.png",
        "date": "2025-10-06 18:12:12",
        "description": "Tarsus Pharmaceuticals, Inc. has shown notable market activity, with a significant stock increase today and impressive gains over the past week and year. The company, operating in the Pharmaceuticals & Biotechnology sector, has reported positive quarterly results and rising promoter confidence, reflecting its strong performance in the market."
      }
    ],
    "total": 22,
    "sid": "1250010",
    "stock_news_url": "https://www.marketsmojo.com/news/tarsus-pharmaceuticals-inc-1250010"
  },
  "announcements": "",
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}

News and Views

Tarsus Pharmaceuticals Hits Day High with 7.33% Surge in Stock Price

2025-10-16 19:06:27

Tarsus Pharmaceuticals, Inc. has shown strong stock performance, with significant gains over various time frames, including a 101.05% return over the past year. The company reported net sales of USD 102.66 million and increased stakeholder holdings, indicating rising confidence in its future prospects within the pharmaceuticals sector.

Tarsus Pharmaceuticals Hits New 52-Week High of $75.01

2025-10-16 18:29:12

Tarsus Pharmaceuticals, Inc. achieved a new 52-week high of USD 75.01 on October 15, 2025, reflecting a 131.18% increase over the past year. The company, with a market cap of USD 2,402 million, has shown positive sales growth and rising promoter confidence, enhancing its industry standing.

Tarsus Pharmaceuticals Hits New 52-Week High of $71.15

2025-10-14 18:57:26

Tarsus Pharmaceuticals, Inc. has achieved a new 52-week high, reflecting its strong performance in the pharmaceuticals and biotechnology sector. With a market capitalization of USD 2,402 million, the company has shown significant growth, positive quarterly results, and increasing promoter confidence, highlighting its resilience and commitment to future prospects.

Tarsus Pharmaceuticals Hits New 52-Week High of $70.58

2025-10-09 20:27:29

Tarsus Pharmaceuticals, Inc. achieved a new 52-week high on October 8, 2025, reflecting its strong performance in the pharmaceuticals and biotechnology sector. With a market cap of USD 2,402 million, the company has shown resilience despite losses, and promoter confidence is increasing as their stake rises.

Tarsus Pharmaceuticals Hits New 52-Week High of $69.49

2025-10-08 16:58:45

Tarsus Pharmaceuticals, Inc. achieved a new 52-week high of USD 69.49 on October 7, 2025, reflecting strong performance in the pharmaceuticals sector. With a market cap of USD 2,402 million and significant net sales, the company has seen increased promoter confidence and impressive one-year growth metrics.

Tarsus Pharmaceuticals Hits New 52-Week High of $68.00

2025-10-07 22:02:11

Tarsus Pharmaceuticals, Inc. achieved a new 52-week high of USD 68.00 on October 6, 2025, reflecting a 108.87% increase over the past year. The company, with a market cap of USD 2,402 million, has shown improving financial results and rising promoter confidence, indicating potential growth in the pharmaceuticals sector.

Tarsus Pharmaceuticals Experiences Evaluation Revision Amid Strong Market Performance Indicators

2025-10-07 20:57:02

Tarsus Pharmaceuticals, Inc. has recently revised its evaluation amid strong market dynamics, with its stock price rising significantly. Over the past year, the company has achieved a remarkable return, outperforming the S&P 500. Technical indicators show a predominantly bullish sentiment, reflecting Tarsus's growth potential in the pharmaceuticals sector.

Is Tarsus Pharmaceuticals, Inc. technically bullish or bearish?

2025-10-07 12:24:17

As of 3 October 2025, the technical trend for Tarsus Pharmaceuticals, Inc. has changed from mildly bullish to bullish. The current stance is bullish with strong indicators supporting this view. The MACD is bullish on both the weekly and monthly time frames, and Bollinger Bands also indicate a bullish trend. Moving averages on the daily chart confirm this bullish sentiment. Although the KST shows a mildly bearish signal on the monthly, the overall Dow Theory is bullish for both weekly and monthly periods. In terms of performance, Tarsus has significantly outperformed the S&P 500 across multiple periods, with a 1-year return of 99.81% compared to the S&P 500's 17.82%, and a 3-year return of 293.46% versus 82.57%....

Tarsus Pharmaceuticals Hits Day High with 10.89% Surge in Stock Price

2025-10-06 18:12:12

Tarsus Pharmaceuticals, Inc. has shown notable market activity, with a significant stock increase today and impressive gains over the past week and year. The company, operating in the Pharmaceuticals & Biotechnology sector, has reported positive quarterly results and rising promoter confidence, reflecting its strong performance in the market.

View All News